Tesamorelin

Tesamorelin High- Purity Research Peptide

Tesamorelin is a synthetic 44-amino acid analogue of Growth Hormone-Releasing Hormone (GHRH), modified with a trans-3-hexenoyl group at the N-terminus for enhanced stability and prolonged activity compared to natural GHRH.

This research peptide works by binding to GHRH receptors in the anterior pituitary gland, stimulating the pulsatile release of endogenous growth hormone (GH). Increased GH levels subsequently elevate IGF-1 (Insulin-like Growth Factor-1), which plays a key role in regulating metabolism, fat breakdown (lipolysis), and lean tissue preservation.

Primary Research Focus:

•  Visceral Fat Reduction — Tesamorelin has been extensively studied for its potential to selectively target and reduce deep abdominal (visceral) adipose tissue while largely sparing subcutaneous fat.

•  Metabolic Health — Investigations into improvements in lipid profiles, including reduced triglycerides and better overall body composition.

•  Growth Hormone Axis — Exploration of its effects on natural GH secretion patterns, IGF-1 levels, and related physiological processes in controlled research settings.

Product Specifications (for GB-Peptides Tesamorelin 10mg):

•  Peptide purity: Research-grade (typically ≥99% as per standard lab testing)

•  Form: Lyophilized powder in a sterile 10mg vial

•  Intended Use: For laboratory research and in vitro/in vivo studies only

•  Storage: Refrigerate at 2–8°C; reconstitute with bacteriostatic water as per standard peptide protocols

Research Use Only. Not intended for human or veterinary consumption.